logo
logo

New View Surgical, Inc. Closes $9M Series B Financing To Fund Initial Market Release Of Its Visionport™ System For Minimally Invasive Surgery

Nov 02, 2021•over 3 years ago

Amount Raised

$9 Million

Round Type

series b

BostonHealth Care

Description

New View Surgical, Inc., an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS), announced that it raised $9M in a Series B financing round to fund the initial market release of its VisionPortTM System. The Series B financing follows the company’s announcement of FDA clearance for its VisionPort System platform in June of this year. The round was led by members of New York Angels with Corza Medical, Inc., IAG Capital Partners, Charleston Angels Partners, Ariel Savannah Angel Partners, Keiretsu Forum, Mid Atlantic Bio Angels (MABA) and SSIP, among others participating in the round.

Company Information

Company

New View Surgical

Location

Boston, Massachusetts, United States

About

New View Surgical is an emerging medical device company focused on the development and commercialization of the VisionPort™ System, a novel surgical imaging and access system for minimally invasive surgery. The company is led by an experienced team of medical device innovators and commercial experts who have come together to design and commercialize impactful solutions that meet a variety of unmet market needs. The company’s proprietary VisionPort™ System combines multiple imaging and access devices into one simple, easy-to-use device that is disposable and is expected to bring a variety of clinical, operational, and financial advantages to minimally invasive surgery operating rooms around the world. For more information, please visit www.newviewsurg.com or follow the company on Twitter at @NewViewSurg.

FundzWatch™ Score

85
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood